Cyclin A-mediated inhibition of intra-Golgi transport requires p34cdc2

FEBS Lett. 1993 Dec 28;336(3):549-54. doi: 10.1016/0014-5793(93)80874-t.

Abstract

An in vitro assay was used to study the role of p34cdc2 in cyclin A-mediated vesicular transport inhibition. It was shown that the S-phase kinase p33cdk2 reduced the effect of cyclin A on transport assays performed with sHeLa cytosol, even though histone kinase was strongly activated. Also, transport with FT210 cytosol (which is temperature-sensitive for p34cdc2) was inhibited by cyclin A only at the permissive temperature. However, the phosphatase inhibitor microcystin inhibited transport without any requirement for p34cdc2 activity. These results show that transport is inhibited by cyclin A via p34cdc2, and also by another kinase, possibly downstream of p34cdc2.

MeSH terms

  • Alkaloids / pharmacology
  • Animals
  • Biological Transport / drug effects
  • CDC2 Protein Kinase / metabolism*
  • CHO Cells
  • Cell Line
  • Cricetinae
  • Cyclins / pharmacology*
  • Cytosol / metabolism
  • Golgi Apparatus / metabolism*
  • HeLa Cells
  • Humans
  • Microcystins
  • Peptides, Cyclic / pharmacology
  • Phosphoprotein Phosphatases / antagonists & inhibitors
  • Protamine Kinase / metabolism
  • Protein Kinase C / antagonists & inhibitors
  • Staurosporine

Substances

  • Alkaloids
  • Cyclins
  • Microcystins
  • Peptides, Cyclic
  • microcystin
  • Protamine Kinase
  • Protein Kinase C
  • CDC2 Protein Kinase
  • Phosphoprotein Phosphatases
  • Staurosporine